About this study The purpose of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic ...

Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and limb events and mortality, researchers reported at the Society for ...

Background: Survival and functional outcome of patients with acute basilar artery occlusion (BAO) are highly dependent on vessel recanalization. Therefore intra-arterial thrombolysis is recommended in ...

Cardiovascular disease is a severe threat to human health. The assessment of the degree of cardiovascular stenosis is very important for the diagnosis of cardiovascular disease. The segmentation of ...

On the heels of STRIDE, one of the first trials to show glucagon-like peptide-1 (GLP-1) receptor agonists can help patients with PAD, a retrospective study of more than 100,000 patients provides more ...

Acute basilar artery occlusion is a serious condition which often results in severe disability or death. 1,2 Several series have suggested that local intra-arterial thrombolysis (IAT) improves basilar ...

Objective To improve early diagnosis of patients who have basilar artery occlusion (BAO) and to provide evidence for treatment decisions based on clinical characteristics, treatment strategies, and ...